What is "isoray"

IsoRay Inc. (IsoRay) is a national isotope-based medical company. With its patented radioisotope technology, the company offers products including Cesium-131 seeds and other relevant treatment medicine for cancer and other malignant diseases. Its subsidiary, IsoRay Medical Inc., is the sole producer of Cesium-131 brachytherapy seeds. In 2006, its patented Cesium-131 brachytherapy seed technology was named as one of 2006's 100 most technologically significant products by R&D Magazine. The company has obtained clearance from the US Food and Drug Administration (FDA) for treatment for all solid tumor applications using its products. In 2010, the company was awarded under the IRS Qualifying Therapeutic Discovery Program (QTDP), which is a project of U.S. Department of Health and Human Services.